Global Translational Regenerative Medicine Market Size, Share, Trends and Forecast 2021-2027

Description

The global Translational Regenerative Medicine market size is projected to reach US$ 26940 million by 2026, from US$ 12610 million in 2019, at a CAGR of 13.5% during 2021-2026.
Global Translational Regenerative Medicine Scope and Segment
Translational Regenerative Medicine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Translational Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2016-2027.
The following manufacturers are covered in this report:
Athersys
Avita Medical
AxoGen
MEDIPOST
NuVasive
Astellas Pharma
Organogenesis Holdings
Osiris Therapeutics
Pharmicell
Regenerys
Takeda Pharmaceutical
uniQure
Vericel
Translational Regenerative Medicine Breakdown Data by Type
Stem Cell Therapy
Tissue Engineering
Gene Therapy
Translational Regenerative Medicine Breakdown Data by Application
Tissue Engineering Therapy
Wound Healing
Cartilage Repair
Other
Regional and Country-level Analysis
The Translational Regenerative Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Translational Regenerative Medicine market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2016-2027. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2016-2027.
Competitive Landscape and Translational Regenerative Medicine Market Share Analysis

TABLE OF CONTENT

1 Study Coverage
1.1 Translational Regenerative Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Translational Regenerative Medicine Market Size Growth Rate by Type
1.4.2 Stem Cell Therapy
1.4.3 Tissue Engineering
1.2.4 Gene Therapy
1.3 Market by Application
1.3.1 Global Translational Regenerative Medicine Market Size Growth Rate by Application
1.3.2 Tissue Engineering Therapy
1.3.3 Wound Healing
1.3.4 Cartilage Repair
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Translational Regenerative Medicine Sales Estimates and Forecasts 2016-2027
2.2 Global Translational Regenerative Medicine Revenue Estimates and Forecasts 2016-2027
2.3 Global Translational Regenerative Medicine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Translational Regenerative Medicine Regions by Sales
2.4.1 Global Top Translational Regenerative Medicine Regions by Sales (2016-2021)
2.4.2 Global Top Translational Regenerative Medicine Regions by Sales (2022-2027)
2.5 Global Top Translational Regenerative Medicine Regions by Revenue
2.5.1 Global Top Translational Regenerative Medicine Regions by Revenue (2016-2021)
2.5.2 Global Top Translational Regenerative Medicine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Translational Regenerative Medicine Sales by Manufacturers
3.1.1 Global Top Translational Regenerative Medicine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Translational Regenerative Medicine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Translational Regenerative Medicine Sales in 2020
3.2 Global Translational Regenerative Medicine Revenue by Manufacturers
3.2.1 Global Top Translational Regenerative Medicine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Translational Regenerative Medicine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Translational Regenerative Medicine Revenue in 2020
3.3 Global Translational Regenerative Medicine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Translational Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Translational Regenerative Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Translational Regenerative Medicine Sales by Type
4.1.1 Global Translational Regenerative Medicine Historical Sales by Type (2016-2021)
4.1.2 Global Translational Regenerative Medicine Forecasted Sales by Type (2022-2027)
4.1.3 Global Translational Regenerative Medicine Sales Market Share by Type (2016-2027)
4.2 Global Translational Regenerative Medicine Revenue by Type
4.2.1 Global Translational Regenerative Medicine Historical Revenue by Type (2016-2021)
4.2.2 Global Translational Regenerative Medicine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Translational Regenerative Medicine Revenue Market Share by Type (2016-2027)
4.3 Global Translational Regenerative Medicine Price by Type
4.3.1 Global Translational Regenerative Medicine Price by Type (2016-2021)
4.3.2 Global Translational Regenerative Medicine Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Translational Regenerative Medicine Sales by Application
5.1.1 Global Translational Regenerative Medicine Historical Sales by Application (2016-2021)
5.1.2 Global Translational Regenerative Medicine Forecasted Sales by Application (2022-2027)
5.1.3 Global Translational Regenerative Medicine Sales Market Share by Application (2016-2027)
5.2 Global Translational Regenerative Medicine Revenue by Application
5.2.1 Global Translational Regenerative Medicine Historical Revenue by Application (2016-2021)
5.2.2 Global Translational Regenerative Medicine Forecasted Revenue by Application (2022-2027)
5.2.3 Global Translational Regenerative Medicine Revenue Market Share by Application (2016-2027)
5.3 Global Translational Regenerative Medicine Price by Application
5.3.1 Global Translational Regenerative Medicine Price by Application (2016-2021)
5.3.2 Global Translational Regenerative Medicine Price Forecast by Application (2022-2027)

6 North America
6.1 North America Translational Regenerative Medicine Market Size by Type
6.1.1 North America Translational Regenerative Medicine Sales by Type (2016-2027)
6.1.2 North America Translational Regenerative Medicine Revenue by Type (2016-2027)
6.2 North America Translational Regenerative Medicine Market Size by Application
6.2.1 North America Translational Regenerative Medicine Sales by Application (2016-2027)
6.2.2 North America Translational Regenerative Medicine Revenue by Application (2016-2027)
6.3 North America Translational Regenerative Medicine Market Size by Country
6.3.1 North America Translational Regenerative Medicine Sales by Country (2016-2027)
6.3.2 North America Translational Regenerative Medicine Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Translational Regenerative Medicine Market Size by Type
7.1.1 Europe Translational Regenerative Medicine Sales by Type (2017-2027)
7.1.2 Europe Translational Regenerative Medicine Revenue by Type (2017-2027)
7.2 Europe Translational Regenerative Medicine Market Size by Application
7.2.1 Europe Translational Regenerative Medicine Sales by Application (2017-2027)
7.2.2 Europe Translational Regenerative Medicine Revenue by Application (2017-2027)
7.3 Europe Translational Regenerative Medicine Market Size by Country
7.3.1 Europe Translational Regenerative Medicine Sales by Country (2017-2027)
7.3.2 Europe Translational Regenerative Medicine Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Translational Regenerative Medicine Market Size by Type
8.1.1 Asia Pacific Translational Regenerative Medicine Sales by Type (2018-2027)
8.1.2 Asia Pacific Translational Regenerative Medicine Revenue by Type (2018-2027)
8.2 Asia Pacific Translational Regenerative Medicine Market Size by Application
8.2.1 Asia Pacific Translational Regenerative Medicine Sales by Application (2018-2027)
8.2.2 Asia Pacific Translational Regenerative Medicine Revenue by Application (2018-2027)
8.3 Asia Pacific Translational Regenerative Medicine Market Size by Region
8.3.1 Asia Pacific Translational Regenerative Medicine Sales by Region (2018-2027)
8.3.2 Asia Pacific Translational Regenerative Medicine Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Translational Regenerative Medicine Market Size by Type
9.1.1 Latin America Translational Regenerative Medicine Sales by Type (2019-2027)
9.1.2 Latin America Translational Regenerative Medicine Revenue by Type (2019-2027)
9.2 Latin America Translational Regenerative Medicine Market Size by Application
9.2.1 Latin America Translational Regenerative Medicine Sales by Application (2019-2027)
9.2.2 Latin America Translational Regenerative Medicine Revenue by Application (2019-2027)
9.3 Latin America Translational Regenerative Medicine Market Size by Country
9.3.1 Latin America Translational Regenerative Medicine Sales by Country (2019-2027)
9.3.2 Latin America Translational Regenerative Medicine Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Translational Regenerative Medicine Market Size by Type
6.1.1 Middle East and Africa Translational Regenerative Medicine Sales by Type (2016-2027)
6.1.2 Middle East and Africa Translational Regenerative Medicine Revenue by Type (2016-2027)
6.2 Middle East and Africa Translational Regenerative Medicine Market Size by Application
6.2.1 Middle East and Africa Translational Regenerative Medicine Sales by Application (2016-2027)
6.2.2 Middle East and Africa Translational Regenerative Medicine Revenue by Application (2016-2027)
6.3 Middle East and Africa Translational Regenerative Medicine Market Size by Country
6.3.1 Middle East and Africa Translational Regenerative Medicine Sales by Country (2016-2027)
6.3.2 Middle East and Africa Translational Regenerative Medicine Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Athersys
11.1.1 Athersys Corporation Information
11.1.2 Athersys Overview
11.1.3 Athersys Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Athersys Translational Regenerative Medicine Product Description
11.1.5 Athersys Related Developments
11.2 Avita Medical
11.2.1 Avita Medical Corporation Information
11.2.2 Avita Medical Overview
11.2.3 Avita Medical Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Avita Medical Translational Regenerative Medicine Product Description
11.2.5 Avita Medical Related Developments
11.3 AxoGen
11.3.1 AxoGen Corporation Information
11.3.2 AxoGen Overview
11.3.3 AxoGen Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 AxoGen Translational Regenerative Medicine Product Description
11.3.5 AxoGen Related Developments
11.4 MEDIPOST
11.4.1 MEDIPOST Corporation Information
11.4.2 MEDIPOST Overview
11.4.3 MEDIPOST Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 MEDIPOST Translational Regenerative Medicine Product Description
11.4.5 MEDIPOST Related Developments
11.5 NuVasive
11.5.1 NuVasive Corporation Information
11.5.2 NuVasive Overview
11.5.3 NuVasive Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 NuVasive Translational Regenerative Medicine Product Description
11.5.5 NuVasive Related Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Corporation Information
11.6.2 Astellas Pharma Overview
11.6.3 Astellas Pharma Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Astellas Pharma Translational Regenerative Medicine Product Description
11.6.5 Astellas Pharma Related Developments
11.7 Organogenesis Holdings
11.7.1 Organogenesis Holdings Corporation Information
11.7.2 Organogenesis Holdings Overview
11.7.3 Organogenesis Holdings Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Organogenesis Holdings Translational Regenerative Medicine Product Description
11.7.5 Organogenesis Holdings Related Developments
11.8 Osiris Therapeutics
11.8.1 Osiris Therapeutics Corporation Information
11.8.2 Osiris Therapeutics Overview
11.8.3 Osiris Therapeutics Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Osiris Therapeutics Translational Regenerative Medicine Product Description
11.8.5 Osiris Therapeutics Related Developments
11.9 Pharmicell
11.9.1 Pharmicell Corporation Information
11.9.2 Pharmicell Overview
11.9.3 Pharmicell Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Pharmicell Translational Regenerative Medicine Product Description
11.9.5 Pharmicell Related Developments
11.10 Regenerys
11.10.1 Regenerys Corporation Information
11.10.2 Regenerys Overview
11.10.3 Regenerys Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Regenerys Translational Regenerative Medicine Product Description
11.10.5 Regenerys Related Developments
11.1 Athersys
11.1.1 Athersys Corporation Information
11.1.2 Athersys Overview
11.1.3 Athersys Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Athersys Translational Regenerative Medicine Product Description
11.1.5 Athersys Related Developments
11.12 uniQure
11.12.1 uniQure Corporation Information
11.12.2 uniQure Overview
11.12.3 uniQure Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 uniQure Product Description
11.12.5 uniQure Related Developments
11.13 Vericel
11.13.1 Vericel Corporation Information
11.13.2 Vericel Overview
11.13.3 Vericel Translational Regenerative Medicine Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Vericel Product Description
11.13.5 Vericel Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Translational Regenerative Medicine Value Chain Analysis
12.2 Translational Regenerative Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Translational Regenerative Medicine Production Mode & Process
12.4 Translational Regenerative Medicine Sales and Marketing
12.4.1 Translational Regenerative Medicine Sales Channels
12.4.2 Translational Regenerative Medicine Distributors
12.5 Translational Regenerative Medicine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Translational Regenerative Medicine Industry Trends
13.2 Translational Regenerative Medicine Market Drivers
13.3 Translational Regenerative Medicine Market Challenges
13.4 Translational Regenerative Medicine Market Restraints

14 Key Findings in The Global Translational Regenerative Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample